CareDx, Inc. (CDNA) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
CareDx (CDNA) Q2 2026: Revenue Soars 52% as NavDx and Transplant Volumes Expand Core Platform
July 31, 2026
-
CareDx (CDNA) Q1 2026: Testing Services Revenue Jumps 48% as Portfolio Reshapes for $12B TAM
April 29, 2026
-
CareDx (CDNA) Q4 2025: Patient & Digital Solutions Up 47%, Underscoring Platform Leverage
February 25, 2026
-
CareDx (CDNA) Q2 2025: Adjusted Revenue Rises 14% as Protocol Adoption and AI Diagnostics Drive Growth
August 06, 2025
-
CareDx (CDNA) Q1 2025: Gross Margin Expands 150bps as Testing Volumes Climb 12%
July 04, 2025